Neuroblastoma in the Era of Precision Medicine: A Clinical Review

SIMPLE SUMMARY: Patients with high-risk neuroblastoma, especially those whose disease either does not respond or recurs, have a poor chance of survival. Additionally, the majority of survivors of modern day high-risk neuroblastoma therapy develop significant late-effects. In an effort to improve sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahba, Andrew, Wolters, Russ, Foster, Jennifer H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571527/
https://www.ncbi.nlm.nih.gov/pubmed/37835416
http://dx.doi.org/10.3390/cancers15194722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571527/
https://www.ncbi.nlm.nih.gov/pubmed/37835416
http://dx.doi.org/10.3390/cancers15194722

Ejemplares similares